Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy

Currently, a marked number of clinical trials on cancer treatment have revealed the success of immunomodulatory therapies based on immune checkpoint inhibitors that activate tumor-specific T cells. However, the therapeutic efficacy of cancer immunotherapies is only restricted to a small fraction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouidhi, Soumaya, Ben Ayed, Farhat, Benammar Elgaaied, Amel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829092/
https://www.ncbi.nlm.nih.gov/pubmed/29527212
http://dx.doi.org/10.3389/fimmu.2018.00353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829092/
https://www.ncbi.nlm.nih.gov/pubmed/29527212
http://dx.doi.org/10.3389/fimmu.2018.00353

Ejemplares similares